This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

21 Feb 2014

A&C American Chemicals Received EXCiPACT Certification as Pharmaceutical Excipient Supplier

EXCiPACT asbl is delighted to announce that A&C American Chemicals of Montreal, Quebec, Canada has received an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally recognised Certification Bodies.  

EXCiPACT Certification demonstrates that this A&C site manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) Certification Standards.  

This is the first North American site to receive such certification. The other certified sites are in Germany (4), France, The Netherlands, and Saudi Arabia.

Both SGS and the auditors they used had to undergo a rigorous assessment process in order to be EXCiPACT registered. Their auditors completed both the formal EXCiPACT training programme and were independently witnessed to verify that their competency was at the required standard.  

EU and US pharmaceutical excipient regulations now require drug manufacturers to do either their own or 3rd party physical audits of all their starting material suppliers to demonstrate GMP and/or GDP compliance. The audit burden is huge. Using GMP and GDP standards designed for excipients, the new, high quality 3rd Party EXCiPACT certification scheme is already helping excipient users and suppliers to reduce their audit burden, save costs and ensure quality.  

Related News